1[1]Ludwig J, Viggiano RT, McGill DB. Nonalcoholic steatohepatitis: Mayo Clinic experience with a hitherto unnamed disease.Mayo Clinic Proc, 1980,55:342 ～ 348
2[2]Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr,2000,36:734 ～ 738
3[3]Hasegawa T, Yoneda M, Nakamura K, et al. Plasma transforming growth factor betal level and effect of α - copherol in patients with non - alcoholic steatohepatitis. Aliment Pharmacol Ther,2001,15:1667 ～ 1672
4[4]Abdelmalek MF,Angulo P,Jorgensen RA,et al. Betain,a promising new agent of patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol, 2001,96:2711～2717
5[5]Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment on non - alcoholic - induced steatohepatitis: a pilot study. Hepatology, 1996,23:1464 ～ 1467
6[6]Keith D, Lindor Kris V, Kowdiey E, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randamized trial. Hepatology,2004 ,39 :770 ～ 778
7[7]Uygun A, Kadayifci A, Isik At, et al. Metformin in the treatment of patients with non - alcoholic steatohepatitis. Aliment Pharmacol Ther,2004,19:537 ～ 544
8[8]Neuschwander - Tetri BA, Brunt EM, Wehmeier KR, et al. Improved non - alcoholic steatohepatitis after 48 weeks of treatment with the PPAR - γ ligand rosiglitazone. Hepatology ,2003,38:1008 ～ 1017
9[9]Kawaguchi K, Sakaida I, Tsuchiya M, et al. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme - altered lesions in rat liver cirrhosis induced by a choline - deficient L - amino aciddefined diet. Biochem Biophys Res Commun, 2004,315 ( 1 ):187 ～ 195
10[10]Rao MS, Papredddy K, Musunmi S, et al. Prevention/reversal of choline deficiency - induced steatohepatitis by a peroxisome proliferator - activated receptor alpha ligands in rats. In Vivo,2002,16:145 ～ 152
